1. Home
  2. PFSA vs IMCC Comparison

PFSA vs IMCC Comparison

Compare PFSA & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PFSA

Profusa Inc.

HOLD

Current Price

$0.22

Market Cap

1.7M

Sector

Health Care

ML Signal

HOLD

Logo IM Cannabis Corp.

IMCC

IM Cannabis Corp.

HOLD

Current Price

$0.24

Market Cap

1.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFSA
IMCC
Founded
2009
1980
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7M
1.7M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
PFSA
IMCC
Price
$0.22
$0.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
220.0K
517.5K
Earning Date
04-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$63.88
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.05
$0.21
52 Week High
$4.22
$3.61

Technical Indicators

Market Signals
Indicator
PFSA
IMCC
Relative Strength Index (RSI) 28.94 41.32
Support Level $0.12 $0.23
Resistance Level $0.41 $0.44
Average True Range (ATR) 0.03 0.05
MACD 0.00 0.00
Stochastic Oscillator 0.00 10.85

Price Performance

Historical Comparison
PFSA
IMCC

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.

Share on Social Networks: